Latest Biotechnology Industry News | Page 14

New trial underway of Pharmaxis’ first-in-class LOX inhibitor
Exopharm announces new agreement with Astellas Institute for Regenerative Medicine
Certainty offered for RDTI clinical trial activities
First patient dosed in Telix ‘ProstACT’ therapeutic program
New partnership between BiomeBank and Hudson Institute
Keynote announced for NSW Women in Life Sciences Luncheon
Technovalia announces interim safety results from vaccine phase 1 trial
Significant capital raise for emerging Australian company
Global biomanufacturing report seeks Australian voice
BiomeBank appoints new chair to accelerate commercialisation strategy
Patients dosed in Dimerix’s DMX-200 Covid late-stage study in India
Pharmaxis welcomes government research grants for new study collaborations
Recharged with resolutions for 2022
CSL Publishes Vifor Offer Prospectus
AusBiotech office closure 21 December
QIMR Berghofer attracts support for potential multiple sclerosis treatment
CSL completes $6.3 billion placement to support Vifor acquisition
Uniting to progress biotech in year ahead
Australia’s health security audit closing with year
CSL Announces Tender Offer To Acquire Vifor Pharma
CSL Committed to mRNA Program
Recce Pharmaceuticals update on clinical trial of burn wound infections
Save date: NSW Women in Life Sciences Luncheon announced
Positive late-stage trial results for Neuren Pharmaceuticals’ trofinetide
Australian-produced eucalyptus compound effective at treating lung damage in sheep mode
2021 Brilliant Women in Digital Health
US FDA grants new fast designation for Bionomics’ BNC210
New discoveries make steps toward lipoedema diagnosis and treatment
Call for Australasian Biotechnology journal abstracts
CSL Joins StartX Community
New BARD1 exosome liquid biopsy agreement with Griffith University
Victoria produces Australia’s first mRNA Covid vaccine candidate
ResApp receives first regulatory approvals for cough counter smartphone application
AusBiotech welcomes Parliamentary Inquiry report
Biotron’s BIT225 effective against Covid in animal study
CSL’s new headquarters will be home to biotech incubator
Member feedback sought on mandatory reporting of adverse events
Melbourne Biotech Incubator
Call for AusMedtech 2022 session submissions
Telix Pharmaceuticals says first Australian patient doses in global study
AusBiotech highlights cell and gene therapy opportunity to Senate Inquiry
Nirtek begins R&D collaboration with TTRA funding support
AusBiotech calls for feedback on National One Stop Shop for clinical trials
Winner of 2021’s Prime Minister’s Prize for Innovation congratulated
Mr Geoffrey Kempler announced as new AusBiotech Chair
TGA approves Telix Pharmaceuticals’ Illuccix for prostate cancer
Decadal Biotech Blueprint opens for sector-wide consultation
Rhinomed announces details of new trial for Rhinoswab